Literature DB >> 10950025

Nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease.

J O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10950025     DOI： 10.1111/j.1572-0241.2000.02241.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  10 in total

Review 1.  Management of arthropathy in inflammatory bowel diseases.

Authors:  Rosario Peluso; Francesco Manguso; Maria Vitiello; Salvatore Iervolino; Matteo Nicola Dario Di Minno
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

Review 2.  Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction?

Authors:  Mario Guslandi
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

3.  Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs.

Authors:  Angela M Meyer; Nizar N Ramzan; Russell I Heigh; Jonathan A Leighton
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

4.  Extraintestinal Complications of Inflammatory Bowel Disease.

Authors:  Ad A. van Bodegraven; Ben A. C. Dijkmans; Paul Lips; Tom J. Stoof; A. Salvador Peña; Stephan G. M. Meuwissen
Journal:  Curr Treat Options Gastroenterol       Date:  2001-06

Review 5.  Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?

Authors:  Helenie Kefalakes; Theodoros J Stylianides; George Amanakis; George Kolios
Journal:  Eur J Clin Pharmacol       Date:  2009-08-27       Impact factor: 2.953

6.  The impact of recent data on our understanding of the roles of COX-1 and COX-2 in gastrointestinal pathophysiology.

Authors:  Ingvar Bjarnason
Journal:  Clin Drug Investig       Date:  2007-12       Impact factor: 2.859

Review 7.  Rheumatological manifestations in inflammatory bowel disease.

Authors:  Paraskevi V Voulgari
Journal:  Ann Gastroenterol       Date:  2011

8.  Administration of Protein Kinase D1 Induces a Protective Effect on Lipopolysaccharide-Induced Intestinal Inflammation in a Co-Culture Model of Intestinal Epithelial Caco-2 Cells and RAW264.7 Macrophage Cells.

Authors:  Ditte Søvsø Gundelund Nielsen; Marlene Fredborg; Vibeke Andersen; Stig Purup
Journal:  Int J Inflam       Date:  2017-10-26

Review 9.  Defining the phenotype, pathogenesis and treatment of Crohn's disease associated spondyloarthritis.

Authors:  Anand Kumar; Dana Lukin; Robert Battat; Monica Schwartzman; Lisa A Mandl; Ellen Scherl; Randy S Longman
Journal:  J Gastroenterol       Date:  2020-05-04       Impact factor: 7.527

Review 10.  Inflammatory Bowel Disease-related Spondyloarthritis: The Last Unexplored Territory of Rheumatology.

Authors:  Nikoleta Zioga; Dionysios Kogias; Vasiliki Lampropoulou; Nikolaos Kafalis; Charalampos Papagoras
Journal:  Mediterr J Rheumatol       Date:  2022-04-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.